Cornelia L. Dekker, M.D.

  • Chair, NIH DMID SMC: Phase I Study to Determine the Human Infectious Doses Causing 50% Infection with the GII.4 Norovirus Filtrate, CIN 1, 2013 - present
  • Chair, NIH DMID SMC: Phase I Study to Determine the Human Infectious Dose Causing 50% Infection with the GII.2 Snow Mountain Norovirus Filtrate, SNM, 2013 - present
  • Member, NIH DMID SMC: 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 through 74 Years of Age, 2012 - present
  • Member, External Data Monitoring Committee for Study Drug: ACC-001 (vanutide cridificar) a joint development project for an Alzheimer’s disease vaccine between Pfizer and Janssen, 2011 - present
  • Member, HIV Vaccine Trial Network Safety Monitoring Board (Chair 2014-present), 2009 - present
  • Member, NIH DMID SMC Evaluation of a Challenge Pool of Norwalk Virus Inocula in Human Subjects, 2008 - present
  • Member, NVAC H1N1 Subgroup, 2009 - 2010
  • Member, NVAC Vaccine Safety Working Group, 2008 - 2011
  • Member, NIH DMID Phase 1A Clinical Study with DAS181 Safety Monitoring Committee, 2007 - 2010
  • Member, National Vaccine Advisory Committee (NVAC), 2005 - 2010
  • Co-chair, NVAC Subcommittee on Vaccine Development and Supply, 2005 - 2008
  • Member and SMC Chair (Pediatric), NIH DMID/Sanofi Pasteur Inactivated Influenza A/H5N1 Vaccine Data Safety Monitoring Board, 2005 - 2007
  • Co-chair, NVAC Working Group on Regulatory Harmonization, 2005 - 2006
  • Member, Trustee Committee, California Association of Independent Schools, 2004 - 2007
  • President, Bentley School Board of Trustees, 2004 - 2007
  • Member, Bentley School Board of Trustees, 2001 - 2004

Stanford Medicine Resources:

Footer Links: